Myriad Genetics (EndoPredict Business Unit) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Myriad Genetics (EndoPredict Business Unit) General Information

Description

Manufacturer of prognostic testing kits intended for breast cancer treatment. The company predicts patients' risk of breast cancer recurrence to help identify who can consider safely forgoing chemotherapy.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Salt Lake City, UT
  • United States
Primary Industry
Diagnostic Equipment
Acquirer
Eurobio Scientific
Vertical(s)
Life Sciences
Corporate Office
  • Salt Lake City, UT
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Myriad Genetics (EndoPredict Business Unit) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Myriad Genetics (EndoPredict Business Unit)‘s full profile, request access.

Request a free trial

Myriad Genetics (EndoPredict Business Unit) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Myriad Genetics (EndoPredict Business Unit)‘s full profile, request access.

Request a free trial

Myriad Genetics (EndoPredict Business Unit) FAQs

  • Where is Myriad Genetics (EndoPredict Business Unit) headquartered?

    Myriad Genetics (EndoPredict Business Unit) is headquartered in Salt Lake City, UT.

  • What industry is Myriad Genetics (EndoPredict Business Unit) in?

    Myriad Genetics (EndoPredict Business Unit)’s primary industry is Diagnostic Equipment.

  • Is Myriad Genetics (EndoPredict Business Unit) a private or public company?

    Myriad Genetics (EndoPredict Business Unit) is a Private company.

  • What is the current valuation of Myriad Genetics (EndoPredict Business Unit)?

    The current valuation of Myriad Genetics (EndoPredict Business Unit) is .

  • What is Myriad Genetics (EndoPredict Business Unit)’s current revenue?

    The current revenue for Myriad Genetics (EndoPredict Business Unit) is .

  • Who are Myriad Genetics (EndoPredict Business Unit)’s investors?

    Myriad Genetics has invested in Myriad Genetics (EndoPredict Business Unit).

  • When was Myriad Genetics (EndoPredict Business Unit) acquired?

    Myriad Genetics (EndoPredict Business Unit) was acquired on 01-Aug-2024.

  • Who acquired Myriad Genetics (EndoPredict Business Unit)?

    Myriad Genetics (EndoPredict Business Unit) was acquired by Eurobio Scientific.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process